Clinical Trial Update: Celecoxib in Parkinson Disease as Adjuvant Therapy [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial evaluating celecoxib as adjuvant therapy for Parkinson disease, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Celecoxib (Celecoxib)

Snippet

Sponsor: Tanta University | Conditions: Parkinson Disease | Phase 1, Phase 2 | Status: RECRUITING